10-Q/A

FORM 10-Q AMENDMENT NO. 1

Company: Oruka Therapeutics, Inc.
Filed: November 6, 2009
Period of Report: March 31, 2009
Accession Number: 0001193125-09-227258

View Document ↗ View on SEC.gov ↗